Tacrolimus leukoencephalopathy: A neuropathologic confirmation

Neurology

Volumn 63, Issue 6, 2004, Pages 1132-1133

  Lavigne, Catherine M ^a   Shrier, David A ^a   Ketkar, Manoj ^a   Powers, James M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ENDOTHELIUM INJURY; FEMALE; HUMAN; LEUKOENCEPHALOPATHY; NEUROPATHOLOGY; NEURORADIOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 4644255201     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000138568.60774.E4     Document Type: Article

References (7)

1. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
2. Ahn KJ, Lee JW, Hahn ST, et al. Diffusion-weighted MRI and ADC mapping in FK506 neurotoxicity. Br J Radiol 2003;76:916-919.
3. Pizzolato GP, Sztajzel R, Burkhardt K, Megret M, Borisch B. Cerebral vasculitis during FK 506 treatment in a liver transplant patient. Neurology 1998;50:1154-1157.
4. Small SL, Fukui MB, Bramblett GT, Eidelman BH. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK 506). Ann Neurol 1996;40:575-580.
5. Power C, Kong PA, Crawford TO, et al. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 1993;34:339-350.
6. Kindt MV, Kemp R, Allen HL, Jensen RD, Patrick DH. Tacrolimus toxicity in rhesus monkey: model for clinical side effects. Transplant Proc 1999;31:3393-3396.
7. Yamauchi A, Ieiri I, Kataoka Y, et al. Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCBl (MDR1) gene. Transplantation 2002;74:571-572.